Investigating the role of neutrophils in dengue virus infection
- Funded by Wellcome Trust
- Total publications:0 publications
Grant number: 227193/Z/23/Z
Grant search
Key facts
Disease
DengueStart & end year
20222025Known Financial Commitments (USD)
$0Funder
Wellcome TrustPrincipal Investigator
Mr. Isaac M DowellResearch Location
United KingdomLead Research Institution
University of BristolResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Disease pathogenesis
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Dengue is an emerging, endemic, mosquito-borne disease in tropical regions worldwide. It causes ~390 million infections and ~40,000 deaths per year. The severity of the disease varies from asymptomatic to fatal in different people, suggesting that an individual's susceptibility and immune responses play a significant role in patients' recovery. Neutrophils are a vital component of the immune system, comprising over 50% of white blood cells in the blood. However, what they do when a person gets dengue is poorly characterised. I aim to determine whether dengue virus can infect or activate neutrophils, how they respond, and how that changes the ability of the virus to infect cells and disease severity. I will analyse the proteins in patients' blood and neutrophils to identify proteins that may be important and will then investigate the role of these in the neutrophil response. I will assess the impact of these proteins on viral infectivity and vascular dysfunction, a symptom of severe dengue disease. This project will help explain the role neutrophils play in dengue infection and whether they have a detrimental effect that increases symptoms. This will be useful in developing new treatments and therapeutics that can help those infected by dengue virus.